Immunologic Agents : Active Immunity (Vaccines and Toxoids)
OROTA2 “RotaTeq oral suspension” 2 ml/vial
適應症：預防輪狀病毒所引起的腸胃炎（G1、G2、G3、G4，以及含有P1〔8〕之G血清型，如G9）。
Usual dose:
Pediatric: PO at 2, 4, and 6 mon of age; first dose between 6 and 14 wks 6 days of age with all 3 doses received by 8 mon of age; separate doses by at least 4 wks; series should not be started for infants 15 wks 0 days or older.
Precaution: febrile illness.
Adverse effect:
Common: diarrhea, vomiting, otitis media.
Serious: seizure.
Related Entries
(Visited 35 times, 1 visits today)